As of November 2024, Keymed Biosciences has a market cap of $1.41B. This makes Keymed Biosciences the world's 6413th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.06B | -39.21% |
2023 | $1.74B | -3.73% |
2022 | $1.81B | 47.83% |
2021 | $1.22B | - |